Development and validation of a nomogram for evaluating the prognosis of immunotherapy plus antiangiogenic therapy in non-small cell lung cancer

HIGHLIGHTS

• who: Hao Huang from the Department of Laboratory Medicine, the First Affiliated Hospital of Sun YatSon University, Guangzhou, Guangdong, China have published the article: Development and validation of a nomogram for evaluating the prognosis of immunotherapy plus antiangiogenic therapy in non-small cell lung cancer, in the Journal: (JOURNAL) of December/31,/2021
• what: The authors aimed to develop a nomogram to examine prognosis of anti-PD-1/PD-L1 antibody plus bevacizumab in non-small cell lung cancer (NSCLC) patients. The authors aimed to use common hematological indicators to develop a nomogram to quantify . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.